Michael C. Lowe, MD, MA

One star
One star
One star
One star
One star

Rating: 5 out of 5 (324 ratings)

Role

Surgical Oncology
Specialty

Skin Cancer and Melanoma
Research Program

Discovery and Developmental Therapeutics
Practicing Since

2014

Call 404-778-0680

Background

Michael C. Lowe, MD, MA, is associate professor in the Division of Surgical Oncology of the Department of Surgery at Emory University School of Medicine and serves as disease team lead and co-chair of the Melanoma Working Group at Winship Cancer Institute of Emory University. A board certified surgical oncologist, Dr. Lowe's primary focus is in cutaneous oncology and specializes in the treatment of cutaneous malignancies including melanoma, basal cell carcinoma and Merkel cell carcinoma.

Dr. Lowe received his MD and graduated cum laude from Georgetown University School of Medicine. He served as administrative chief resident during the final year of his general surgery residency at the Emory Department of Surgery. He joined the Emory faculty after completing a fellowship in complex general surgical oncology at Memorial Sloan Kettering Cancer Center. Dr. Lowe received several awards during his training years, including the Young Investigator Award of the American Society of Transplant Surgeons in 2011 and 2012.

In 2018, Dr. Lowe received the Society of Surgical Oncology's (SSO) Young Investigator Award for his study, "Evaluation of FcyRIIB as a Novel T cell Inhibitor in Cutaneous Melanoma." The study is investigating new pathways to enhance the immune system's response to melanoma, and is focusing on defining the role of the Fc receptor FcyRIIB in promoting exhaustion in T cell responses to tumor growth. The work will examine the benefits of blocking FcyRIIB's ability to alter T cell responses.

Titles & Roles

Associate Professor, Division of Surgical Oncology, Department of Surgery

Emory University School of Medicine
Disease Team Lead and Co-Chair, Melanoma Working Group

Winship Cancer Institute of Emory University
Chair, Protocol Review and Monitoring Committee

Winship Cancer Institute of Emory University

Education & Training

Education

Fellowship, Surgical Oncology, 2016
Memorial Sloan Kettering Cancer Center
Residency, 2014
Emory University School of Medicine
Internship, General Surgery, 2008
Emory University School of Medicine
Medical Education, Medicine, 2007
Georgetown University School of Medicine

Board Certifications

Complex General Surgical Oncology
American Board of Surgery, 2016
Surgery
American Board of Surgery, 2014

Professional Memberships

American College of Surgeons
American Society of Clinical Oncology
Eastern Cooperative Oncology Group: Surgery and Melanoma Committees
Society of Surgical Oncology
Society for Melanoma Research
Association for Academic Surgery
Southeastern Surgical Congress

Research

View Current Clinical Trials


A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma Phase II/III Conditions Metastatic Uveal Melanoma Location Winship Cancer Institute
Excision of Lymph Node Trial (EXCILYNT) (Mel69) Phase II Conditions Melanoma Location Winship Cancer Institute
Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer Phase I/II Conditions Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Merkel Cell Carcinoma AJCC v8, Metastatic Basal Cell Carcinoma, Metastatic Carcinoma in the Skin, Metastatic Melanoma, Metastatic Merkel Cell Carcinoma, Metastatic Skin Squamous Cell Carcinoma, Unresectable Basal Cell Carcinoma, Unresectable Melanoma, Unresectable Merkel Cell Carcinoma, Unresectable Skin Squamous Cell Carcinoma Location Winship Cancer Institute
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma Phase III Conditions Cutaneous Melanoma, Stage II Location Emory University Hospital Midtown, Emory Saint Joseph's Hospital, Winship Cancer Institute
Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C Melanoma Patients Phase III Conditions Melanoma Stage IIIB/C Location Winship Cancer Institute

Publications

Title/Journal	Authors	Publication Date
An Open-label, Randomized Study of Melphalan/Hepatic Delivery System Versus Best Alternative Care in Patients with Unresectable Metastatic Uveal Melanoma. Annals of surgical oncology	JS Zager, M Orloff, PF Ferrucci, J Choi, DJ Eschelman, ES Glazer, A Ejaz, JH Howard, E Richtig, S Ochsenreither, SA Reddy, MC Lowe, GM Beasley, A Gesierich, A Bender, M Gschnell, R Dummer, M Rivoire, A Arance, SW Fenwick, JJ Sacco, S Haferkamp, C Weishaupt, J John, M Wheater, CH Ottensmeier	07/01/2025
The Landmark Series: Melanoma and Adjuvant Therapy. Annals of surgical oncology	MC Lowe, KA Delman, DW Ollila	05/01/2025
Combination radiation and αPD-L1 enhance tumor control by stimulating CD8+ PD-1+ TCF-1+ T cells in the tumor-draining lymph node. Nature communications	Y Shen, E Connolly, M Aiello, C Zhou, P Chappa, H Song, P Tippitak, T Clark, M Cardenas, N Prokhnevska, A Mariniello, I De Bruyker, MS Pagadala, VR Dhere, S Rafiq, AH Kesarwala, A Orthwein, SN Thomas, SL Zhang, MK Khan, JB Dixon, GB Lesinski, MC Lowe, H Kissick, DS Yu, CM Paulos, NC Schmitt, ZS Buchwald	04/14/2025
The association of azole antifungals with overall survival in patients with non-small cell lung cancer receiving immune checkpoint inhibitors. The oncologist	NT Sebastian, WA Stokes, M Behera, R Jiang, DA Gutman, Z Huang, A Burns, V Sukhatme, MC Lowe, SS Ramalingam, VP Sukhatme, D Moghanaki	02/06/2025
Efficacy and Safety of the Melphalan/Hepatic Delivery System in Patients with Unresectable Metastatic Uveal Melanoma: Results from an Open-Label, Single-Arm, Multicenter Phase 3 Study. Annals of surgical oncology	JS Zager, M Orloff, PF Ferrucci, J Choi, DJ Eschelman, ES Glazer, A Ejaz, JH Howard, E Richtig, S Ochsenreither, SA Reddy, MC Lowe, GM Beasley, A Gesierich, A Bender, M Gschnell, R Dummer, M Rivoire, A Arance, SW Fenwick, JJ Sacco, S Haferkamp, C Weishaupt, J John, M Wheater, CH Ottensmeier	08/01/2024
ASO Visual Abstract: Efficacy and Safety of Melphalan/Hepatic Delivery System in Patients with Unresectable Metastatic Uveal Melanoma: Results from an Open-Label, Single-Arm, Multicenter, Phase 3 Study. Annals of surgical oncology	JS Zager, M Orloff, PF Ferrucci, J Choi, DJ Eschelman, ES Glazer, A Ejaz, JH Howard, E Richtig, S Ochsenreither, SA Reddy, MC Lowe, GM Beasley, A Gesierich, A Bender, M Gschnell, R Dummer, M Rivoire, A Arance, SW Fenwick, JJ Sacco, S Haferkamp, C Weishaupt, J John, M Wheater, CH Ottensmeier	08/01/2024
Impact of immunotherapy time-of-day infusion on survival and immunologic correlates in patients with metastatic renal cell carcinoma: a multicenter cohort analysis. Journal for immunotherapy of cancer	JS Patel, Y Woo, A Draper, CS Jansen, JW Carlisle, PF Innominato, FA Lévi, L Dhabaan, VA Master, MA Bilen, MK Khan, MC Lowe, H Kissick, ZS Buchwald, DC Qian	03/26/2024
Radiation and anti-PD-L1 synergize by stimulating a stem-like T cell population in the tumor-draining lymph node. Research square	Y Shen, E Connolly, M Aiello, C Zhou, P Chappa, H Song, P Tippitak, T Clark, M Cardenas, N Prokhnevska, A Mariniello, MS Pagadala, VR Dhere, S Rafiq, AH Kesarwala, A Orthwein, SN Thomas, MK Khan, J Brandon Dixon, GB Lesinski, MC Lowe, H Kissick, DS Yu, CM Paulos, NC Schmitt, ZS Buchwald	03/06/2024
Metastasectomy in Stage IV Melanoma: How and When Should We Employ It? Annals of surgical oncology	MB Faries, M Lowe	09/01/2023
FcγRIIB expressed on CD8⁺ T cells limits responsiveness to PD-1 checkpoint inhibition in cancer. Science translational medicine	KB Bennion, M Tariq, MM Wyatt, C Duneton, KM Baecher, CM Paulos, RR Kudchadkar, MC Lowe, ML Ford	08/23/2023
International Center-Level Variation in Utilization of Completion Lymph Node Dissection and Adjuvant Systemic Therapy for Sentinel Lymph Node-Positive Melanoma at Major Referral Centers. Annals of surgery	KK Broman, TM Hughes, BC Bredbeck, J Sun, D Kirichenko, MJ Carr, A Sharma, EK Bartlett, AAG Nijhuis, JF Thompson, TJ Hieken, L Kottschade, J Downs, DE Gyorki, E Stahlie, A van Akkooi, DW Ollila, K O'shea, Y Song, G Karakousis, M Moncrieff, J Nobes, J Vetto, D Han, M Hotz, JM Farma, JL Deneve, MD Fleming, M Perez, K Baecher, M Lowe, RO Bagge, J Mattsson, AY Lee, RS Berman, H Chai, HM Kroon, J Teras, RM Teras, NE Farrow, GM Beasley, JYC Hui, L Been, S Kruijff, B Sinco, AA Sarnaik, VK Sondak, JS Zager, LA Dossett	05/01/2023
The Association of Improved Overall Survival with NSAIDs in Non-Small Cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitors. Clinical lung cancer	NT Sebastian, WA Stokes, M Behera, R Jiang, DA Gutman, Z Huang, A Burns, V Sukhatme, MC Lowe, SS Ramalingam, VP Sukhatme, D Moghanaki	05/01/2023
HIV-1 DNA and Immune Activation Levels Differ for Long-Lived T-Cells in Lymph Nodes, Compared with Peripheral Blood, during Antiretroviral Therapy. Journal of virology	C Mallarino-Haeger, M Pino, EG Viox, A Pagliuzza, CT King, K Nguyen, JL Harper, SDM Aldrete, B Cervasi, KA Delman, MC Lowe, N Chomont, VC Marconi, M Paiardini	04/27/2023
Neoadjuvant-Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma. The New England journal of medicine	SP Patel, M Othus, Y Chen, GP Wright, KJ Yost, JR Hyngstrom, S Hu-Lieskovan, CD Lao, LA Fecher, TG Truong, JL Eisenstein, S Chandra, JA Sosman, KL Kendra, RC Wu, CE Devoe, GB Deutsch, A Hegde, M Khalil, A Mangla, AM Reese, MI Ross, AS Poklepovic, GQ Phan, AA Onitilo, DG Yasar, BC Powers, GC Doolittle, GK In, N Kokot, GT Gibney, MB Atkins, M Shaheen, JA Warneke, A Ikeguchi, JE Najera, B Chmielowski, JG Crompton, JD Floyd, E Hsueh, KA Margolin, WA Chow, KF Grossmann, E Dietrich, VG Prieto, MC Lowe, EI Buchbinder, JM Kirkwood, L Korde, J Moon, E Sharon, VK Sondak, A Ribas	03/02/2023
Impact of concomitant fibrates on immunotherapy outcomes for advanced non-small cell lung cancer. Cancer medicine	WA Stokes, M Behera, R Jiang, DA Gutman, Z Huang, A Burns, NT Sebastian, V Sukhatme, MC Lowe, SS Ramalingam, VP Sukhatme, D Moghanaki	01/01/2023
Regional control after precision lymph node dissection for clinically evident melanoma metastasis. Journal of surgical oncology	KT Lynch, Y Hu, NE Farrow, Y Song, MO Meneveau, M Kwak, MC Lowe, EK Bartlett, GM Beasley, GC Karakousis, CL Slingluff	01/01/2023
Patterns of recurrence and prognosis in pathologic stage I and II Merkel cell carcinoma: A multicenter, retrospective cohort analysis. Journal of the American Academy of Dermatology	AD Tieniber, AB Shannon, MJ Carr, J Sun, K Landa, KM Baecher, K Lynch, HG Bartels, R Panchaud, MC Lowe, CL Slingluff, MJ Jameson, KY Tsai, MB Faries, GM Beasley, VK Sondak, GC Karakousis, JS Zager, JT Miura	01/01/2023
An Internally Validated Prognostic Risk-Score Model for Disease-Specific Survival in Clinical Stage I and II Merkel Cell Carcinoma. Annals of surgical oncology	AB Shannon, RJ Straker, MJ Carr, J Sun, K Landa, K Baecher, K Lynch, HG Bartels, R Panchaud, LJ Keele, MC Lowe, CL Slingluff, MJ Jameson, KY Tsai, MB Faries, GM Beasley, VK Sondak, GC Karakousis, JS Zager, JT Miura	10/01/2022
ASO Visual Abstract: An Internally Validated Prognostic Risk Score Model for Disease-Specific Survival in Clinical Stage I and II Merkel Cell Carcinoma. Annals of surgical oncology	AB Shannon, RJ Straker, MJ Carr, J Sun, K Landa, K Baecher, K Lynch, HG Bartels, R Panchaud, LJ Keele, MC Lowe, CL Slingluff, MJ Jameson, KY Tsai, MB Faries, GM Beasley, VK Sondak, GC Karakousis, JS Zager, JT Miura	10/01/2022
Oncologic Outcomes of Multi-Institutional Minimally Invasive Inguinal Lymph Node Dissection for Melanoma Compared with Open Inguinal Dissection in the Second Multicenter Selective Lymphadenectomy Trial (MSLT-II). Annals of surgical oncology	JW Jakub, M Lowe, JH Howard, JM Farma, A Sarnaik, T Tuttle, HB Neuman, CE Ariyan, A Uppal, S Trocha, GM Beasley, N Wasif, KY Bilimoria, AA Thomay, JB Allred, L Chen, AM Terando, JD Wayne, JF Thompson, AJ Cochran, MS Sim, DE Elashoff, KA Delman, MB Faries	09/01/2022
Correction to: Neoadjuvant Systemic Therapy (NAST) in Patients with Melanoma: Surgical Considerations by the International Neoadjuvant Melanoma Consortium (INMC). Annals of surgical oncology	ACJ van Akkooi, TJ Hieken, EM Burton, C Ariyan, PA Ascierto, SVMA Asero, CU Blank, MS Block, GM Boland, C Caraco, S Chng, BS Davidson, JP Duprat Neto, MB Faries, JE Gershenwald, DJ Grunhagen, DE Gyorki, D Han, AJ Hayes, WJ van Houdt, GC Karakousis, WMC Klop, GV Long, MC Lowe, AM Menzies, RO Bagge, TE Pennington, P Rutkowski, RPM Saw, RA Scolyer, KF Shannon, VK Sondak, H Tawbi, AAE Testori, MT Tetzlaff, JF Thompson, JS Zager, CL Zuur, JA Wargo, AJ Spillane, MI Ross	08/01/2022
Outcomes with adjuvant anti-PD-1 therapy in patients with sentinel lymph node-positive melanoma without completion lymph node dissection. Journal for immunotherapy of cancer	Z Eroglu, KK Broman, JF Thompson, A Nijhuis, TJ Hieken, L Kottschade, JM Farma, M Hotz, J Deneve, M Fleming, EK Bartlett, A Sharma, L Dossett, T Hughes, DE Gyorki, J Downs, G Karakousis, Y Song, A Lee, RS Berman, A van Akkooi, E Stahlie, D Han, J Vetto, G Beasley, NE Farrow, JYC Hui, M Moncrieff, J Nobes, K Baecher, M Perez, M Lowe, DW Ollila, FA Collichio, RO Bagge, J Mattsson, HM Kroon, H Chai, J Teras, J Sun, MJ Carr, A Tandon, NA Babacan, Y Kim, M Naqvi, J Zager, NI Khushalani	08/01/2022
Neoadjuvant Systemic Therapy (NAST) in Patients with Melanoma: Surgical Considerations by the International Neoadjuvant Melanoma Consortium (INMC). Annals of surgical oncology	ACJ van Akkooi, TJ Hieken, EM Burton, C Ariyan, PA Ascierto, SVMA Asero, CU Blank, MS Block, GM Boland, C Caraco, S Chng, BS Davidson, JP Duprat Neto, MB Faries, JE Gershenwald, DJ Grunhagen, DE Gyorki, D Han, AJ Hayes, WJ van Houdt, GC Karakousis, WMC Klop, GV Long, MC Lowe, AM Menzies, R Olofsson Bagge, TE Pennington, P Rutkowski, RPM Saw, RA Scolyer, KF Shannon, VK Sondak, H Tawbi, AAE Testori, MT Tetzlaff, JF Thompson, JS Zager, CL Zuur, JA Wargo, AJ Spillane, MI Ross	06/01/2022
A Phase III, Multicenter, Randomized Controlled Trial Investigating 1-cm Versus 2-cm Surgical Excision Margins for Stage II Primary Cutaneous Melanoma (MelMarT-II). Annals of surgical oncology	AJ Rossi, EA Verbus, MB Faries, M Moncrieff, M Henderson, JM Hernandez, MC Lowe	04/22/2022
Do Oncologic Outcomes From Head and Neck Versus Truncal and Extremity Melanoma Differ? A Single-Institution Single-Subspecialty Experience. The American surgeon	KM Baecher, MK Turgeon, CR Medin, G Mahendran, TM Flakes, KA Delman, MC Lowe	03/01/2022
Ford Versus Ferrari: Novel Technologies in the Setting of a Reliable Standard. Annals of surgical oncology	KA Delman, MC Mason, MC Lowe	02/01/2022
Talimogene Laherparepvec (T-VEC) for the Treatment of Advanced Locoregional Melanoma After Failure of Immunotherapy: An International Multi-Institutional Experience. Annals of surgical oncology	MJ Carr, J Sun, D DePalo, LD Rothermel, Y Song, RJ Straker, K Baecher, RJ Louie, EHA Stahlie, GP Wright, SMH Naqvi, Y Kim, AA Sarnaik, GC Karakousis, MC Lowe, KA Delman, ACJ van Akkooi, DW Ollila, F Collichio, JS Zager	02/01/2022
Correction to: The Devil's in the Details: Discrepancy Between Biopsy Thickness and Final Pathology in Acral Melanoma. Annals of surgical oncology	AY Lee, EB Friedman, J Sun, A Potdar, H Daou, NE Farrow, CR Farley, JT Vetto, D Han, M Tariq, R Shapiro, G Beasley, CM Contreras, I Osman, M Lowe, JS Zager, RS Berman	12/01/2021
Predictors of False Negative Sentinel Lymph Node Biopsy in Clinically Localized Merkel Cell Carcinoma. Annals of surgical oncology	RJ Straker, MJ Carr, AJ Sinnamon, AB Shannon, J Sun, K Landa, KM Baecher, C Wood, K Lynch, HG Bartels, R Panchaud, MC Lowe, CL Slingluff, MJ Jameson, K Tsai, MB Faries, GM Beasley, V Sondak, GC Karakousis, JS Zager, JT Miura	11/01/2021
In Search of a More Accurate Nodal Staging System for Melanoma: Should We Sacrifice Simplicity? JAMA surgery	K Baecher, K Delman, M Lowe	11/01/2021
ASO Author Reflections: Cutaneous Melanoma as Model System for the Obesity Paradox in Cancer. Annals of surgical oncology	C Harrell Shreckengost, MC Lowe	10/01/2021
The Impact of Obesity on Surgically Treated Locoregional Melanoma. Annals of surgical oncology	CS Harrell Shreckengost, M Tariq, CR Farley, C Zhang, KA Delman, RR Kudchadkar, MC Lowe	10/01/2021
Increased homeostatic cytokines and stability of HIV-infected memory CD4 T-cells identify individuals with suboptimal CD4 T-cell recovery on-ART. PLoS pathogens	M Pino, S Pereira Ribeiro, A Pagliuzza, K Ghneim, A Khan, E Ryan, JL Harper, CT King, S Welbourn, L Micci, S Aldrete, KA Delman, T Stuart, M Lowe, JM Brenchley, CA Derdeyn, K Easley, RP Sekaly, N Chomont, M Paiardini, VC Marconi	08/01/2021
Active surveillance of patients who have sentinel node positive melanoma: An international, multi-institution evaluation of adoption and early outcomes after the Multicenter Selective Lymphadenectomy Trial II (MSLT-2). Cancer	KK Broman, T Hughes, L Dossett, J Sun, D Kirichenko, MJ Carr, A Sharma, EK Bartlett, AAG Nijhuis, JF Thompson, TJ Hieken, L Kottschade, J Downs, DE Gyorki, E Stahlie, A van Akkooi, DW Ollila, J Frank, Y Song, G Karakousis, M Moncrieff, J Nobes, J Vetto, D Han, JM Farma, JL Deneve, MD Fleming, MC Perez, MC Lowe, R Olofsson Bagge, J Mattsson, AY Lee, RS Berman, H Chai, HM Kroon, J Teras, RM Teras, NE Farrow, G Beasley, JYC Hui, L Been, S Kruijff, Y Kim, SMH Naqvi, AA Sarnaik, VK Sondak, JS Zager	07/01/2021
Surveillance of Sentinel Node-Positive Melanoma Patients with Reasons for Exclusion from MSLT-II: Multi-Institutional Propensity Score Matched Analysis. Journal of the American College of Surgeons	KK Broman, TM Hughes, LA Dossett, J Sun, MJ Carr, DA Kirichenko, A Sharma, EK Bartlett, AA Nijhuis, JF Thompson, TJ Hieken, L Kottschade, J Downs, DE Gyorki, E Stahlie, A van Akkooi, DW Ollila, J Frank, Y Song, G Karakousis, M Moncrieff, J Nobes, J Vetto, D Han, J Farma, JL Deneve, MD Fleming, M Perez, K Baecher, M Lowe, RO Bagge, J Mattsson, AY Lee, RS Berman, H Chai, HM Kroon, RM Teras, J Teras, NE Farrow, GM Beasley, JY Hui, L Been, S Kruijff, D Boulware, AA Sarnaik, VK Sondak, JS Zager	04/01/2021
The evolving landscape of immunotherapy in solid tumors. Journal of surgical oncology	JM Keilson, HM Knochelmann, CM Paulos, RR Kudchadkar, MC Lowe	03/01/2021
FcγRIIB is a T cell checkpoint in antitumor immunity. JCI insight	CR Farley, AB Morris, M Tariq, KB Bennion, S Potdar, R Kudchadkar, MC Lowe, ML Ford	02/22/2021
Acral Lentiginous Melanoma: A United States Multi-Center Substage Survival Analysis. Cancer control : journal of the Moffitt Cancer Center	AM Kolla, GA Vitiello, EB Friedman, J Sun, A Potdar, H Daou, NE Farrow, CR Farley, JT Vetto, D Han, M Tariq, GM Beasley, CM Contreras, M Lowe, JS Zager, I Osman, RS Berman, TN Liebman, JA Stein, AY Lee	01/01/2021
Oncologic Outcomes After Isolated Limb Infusion for Advanced Melanoma: An International Comparison of the Procedure and Outcomes Between the United States and Australia. Annals of surgical oncology	MJ Carr, J Sun, HM Kroon, JT Miura, GM Beasley, NE Farrow, PJ Mosca, MC Lowe, CR Farley, Y Kim, SMH Naqvi, DA Kirichenko, A Potdar, H Daou, D Mullen, JM Farma, MA Henderson, D Speakman, J Serpell, KA Delman, BM Smithers, BJ Coventry, DS Tyler, JF Thompson, JS Zager	12/01/2020
The Devil's in the Details: Discrepancy Between Biopsy Thickness and Final Pathology in Acral Melanoma. Annals of surgical oncology	AY Lee, EB Friedman, J Sun, A Potdar, H Daou, NE Farrow, CR Farley, JT Vetto, D Han, M Tariq, R Shapiro, G Beasley, CM Contreras, I Osman, M Lowe, JS Zager, RS Berman	12/01/2020
Factors predicting toxicity and response following isolated limb infusion for melanoma: An international multi-centre study. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology	TJ Kenyon-Smith, HM Kroon, JT Miura, J Teras, GM Beasley, D Mullen, NE Farrow, PJ Mosca, MC Lowe, CR Farley, A Potdar, H Daou, J Sun, JM Farma, MA Henderson, D Speakman, J Serpell, KA Delman, BM Smithers, A Barbour, BJ Coventry, DS Tyler, JS Zager, JF Thompson	11/01/2020
Management of Melanoma Patients with Positive Nodes. Advances in surgery	RM Lee, KA Delman, MC Lowe	09/01/2020
Reducing injury response to surgery with repurposed drugs: An evolving approach to prevention of cancer metastases. Cancer	M Lowe, VV Sukhatme, VP Sukhatme	09/01/2020
Neoadjuvant Therapy for Melanoma. Surgical oncology clinics of North America	MC Lowe, RR Kudchadkar	07/01/2020
The (R)evolution of Melanoma Care. Surgical oncology clinics of North America	KA Delman, MC Lowe	07/01/2020
International Multicenter Experience of Isolated Limb Infusion for In-Transit Melanoma Metastases in Octogenarian and Nonagenarian Patients. Annals of surgical oncology	J Teras, HM Kroon, JT Miura, T Kenyon-Smith, GM Beasley, D Mullen, NE Farrow, PJ Mosca, MC Lowe, CR Farley, A Potdar, H Daou, J Sun, M Carr, JM Farma, MA Henderson, D Speakman, J Serpell, KA Delman, BM Smithers, A Barbour, DS Tyler, BJ Coventry, JS Zager, JF Thompson	05/01/2020
Metastatic melanoma. CA: a cancer journal for clinicians	RR Kudchadkar, MC Lowe, MK Khan, SM McBrien	03/01/2020
Surgical Considerations and Systemic Therapy of Melanoma. The Surgical clinics of North America	AC Gamboa, M Lowe, ML Yushak, KA Delman	02/01/2020
A Call to Arms: Surgeons Must Play an Important and Early Role in the Management of Patients with Advanced Melanoma. Annals of surgical oncology	MC Lowe, KA Delman	12/01/2019
Triple therapy with intralesional 5-fluorouracil, chemowraps, and acitretin: A well-tolerated option for treatment of widespread cutaneous squamous cell carcinomas on the legs. JAAD case reports	IF Manalo, MC Lowe, KC Nelson, SC Chen	12/01/2019
Long-Term Oncologic Outcomes After Isolated Limb Infusion for Locoregionally Metastatic Melanoma: An International Multicenter Analysis. Annals of surgical oncology	JT Miura, HM Kroon, GM Beasley, D Mullen, NE Farrow, PJ Mosca, MC Lowe, CR Farley, Y Kim, SMH Naqvi, A Potdar, H Daou, J Sun, JM Farma, MA Henderson, D Speakman, J Serpell, KA Delman, B Mark Smithers, BJ Coventry, DS Tyler, JF Thompson, JS Zager	08/01/2019
Management of intussusception in patients with melanoma. Journal of surgical oncology	MC Perez, J Sun, C Farley, D Han, AH Sun, D Narayan, M Lowe, KA Delman, JL Messina, RJ Gonzalez, VK Sondak, NI Khushalani, JS Zager	06/01/2019
Real-World Outcomes of Talimogene Laherparepvec Therapy: A Multi-Institutional Experience. Journal of the American College of Surgeons	RJ Louie, MC Perez, MR Jajja, J Sun, F Collichio, KA Delman, M Lowe, AA Sarnaik, JS Zager, DW Ollila	04/01/2019
Neoadjuvant Treatments for Advanced Resectable Melanoma. Journal of surgical oncology	JY Liu, M Lowe	01/01/2019
Neoadjuvant therapy of locally/regionally advanced melanoma. Therapeutic advances in medical oncology	A Khunger, ZS Buchwald, M Lowe, MK Khan, KA Delman, AA Tarhini	01/01/2019
ASO Author Reflections: Optimizing the Outcomes for Patients: The Evolution of the Management of Regional Disease in Patients with Melanoma. Annals of surgical oncology	MC Lowe, CR Farley, KA Delman	12/01/2018
Recurrence Patterns after Primary Excision of Invasive Melanoma with Melanoma in situ at the Margin. The American surgeon	G Oh, CR Farley, AG Lopez-Aguiar, MC Russell, KA Delman, MC Lowe	08/01/2018

Awards

Junior Resident Teaching Award, 2019
Young Investigator Award, Society of Surgical Oncology, 2018
Young Investigator Award, American Society of Transplant Surgeons, 2011, 2012
Robbins Fellowship in Islet Transplantation, 2011
Best Basic Science Presentation, Emory Department of Surgery Research Symposium, 2011
J.D. Martin Surgical Resident Award, Emory Department of Surgery, 2010
Best Clinical Science Oral Presentation, Georgia Chapter, American College of Surgeons, 2009
Alpha Omega Alpha, 2006
Phi Beta Kappa, 2001

Ratings & Reviews

Patients who are treated in outpatient and inpatient environments are eligible to receive a survey related to their individual care. Displayed ratings and reviews are displayed for Providers who have received at least 30 returned surveys over a 12-month period and are related to all Care Provider related survey questions. To help our patients better understand our Transparency program (ratings and review), the motivations behind it, how ratings are calculated, why ratings and reviews are not published for every EHC Provider, and how this information can be helpful for our patients, please click here.

5	One star One star One star One star One star	Provider showed concern
4.9	One star One star One star One star One half star	Provider explained things clearly
5	One star One star One star One star One star	Provider discussed treatment options
5	One star One star One star One star One star	Provider included you in decisions
5	One star One star One star One star One star	Likelihood of recommending this provider

View Reviews


One star One star One star One star One star	05/23/2025	Dr. Lowe explained everything and answered all of our questions and concerns.
One star One star One star One star One star	05/15/2025	Always have excellent care and I appreciate being listened to. It's always a pleasure to come in for my exams.
One star One star One star One star One star	05/05/2025	I always have a good experience.
One star One star One star One star One star	04/30/2025	Everyone caring and supportive
One star One star One star One star One star	04/25/2025	The medical professional showed impressive attention to my good health.
One star One star One star One star One star	04/25/2025	Dr. Lowe was very professional, courteous, informative, empathetic, patient with my questions and his answers
One star One star One star One star One star	04/23/2025	Doctor Lowe was great
One star One star One star One star One star	04/23/2025	Excellent care and understanding of my situation.
One star One star One star One star One star	04/02/2025	Everyone was super!
One star One star One star One star One star	03/26/2025	Dr. Lowe is an excellent doctor. He's well informed about his field and my medical history. He's also carefyl and very empathic often knowing what was on my mind without my explaining.
One star One star One star One star One star	03/12/2025	Full explanation with alternatives, pros & cons of each choice, never rushed. Looked us in the eyes.
One star One star One star One star One star	03/12/2025	Dr. Lowe and the other female Doctor who saw me first (unfortunately I can't remember her name) were both very professional, courteous, patient, informative and empathetic
One star One star One star One star One star	02/21/2025	Dr. Lowe is great. I never feel rushed, and he takes the time to make sure that all of my questions or concerns are addressed.
One star One star One star One star One star	02/08/2025	Dr. Lowe and his staff are the best!
One star One star One star One star One star	01/31/2025	Complex problem explained very well.
One star One star One star One star One star	01/31/2025	Dr Lowe is that rare combination of technically brilliant and socially compassionate. Anyone would be indeed fortunate to have him as their doctor.
One star One star One star One star One star	01/29/2025	Dr. LOWE IS A WONDERFUL DOCTOR!
One star One star One star One star One star	01/16/2025	The doctor assessed my condition quickly and accurately. She had reviewed my history and was well aware of my reason for visiting.
One star One star One star One star One star	01/11/2025	The PA that saw me was engaging, caring and professional.
One star One star One star One star One star	01/10/2025	Would definitely recommend
One star One star One star One star One star	01/08/2025	Dr Lowe explains information in a manner that is easy to understand. He made me feel much better about my condition at this time.
One star One star One star One star One star	01/04/2025	Excellent experience with Physician Assistant. Was very excited to pass on good news about basic remission of cancer and thorough in discussion as to follow up treatments going forward.
One star One star One star One star One star	11/28/2024	Really appreciate being seen with no delay!
One star One star One star One star One star	11/23/2024	Dr Lowe is a compassionate and excellent surgeon.
One star One star One star One star One star	11/20/2024	Good
One star One star One star One star One star	11/14/2024	WONDERFUL! We would never choose to go through cancer, but in hindsight, God directed every step and people we met through the treatment, surgery and recovery. Thanking God for each of you for being there for me and my family
One star One star One star One star One star	11/13/2024	Dr. Lowe and the entire staff/all employees are wonderful. Dr Lowe really helped me feel at ease, relieved, and I love how he helps with aftercare/telling me what to do to help heal.
One star One star One star One star One star	11/06/2024	Dr. Lowe is amazing. He listened to me and he is actually working with me and a team of doctors to provide me with the best care
One star One star One star One star One star	11/01/2024	Dr Mike Lowe is amazing. He inspires confidence with his straight forward and informative consultation. Much impressed!
One star One star One star One star One star	11/01/2024	Answered every question even silly ones; very patient and caring; validated my concerns
One star One star One star One star One star	10/24/2024	Dr. Lowe is patient, informative, kind to answer all kinds of questions when we "grill" him. He displays the logic behind how and why he comes to the decisions/suggestions he makes. It is obvious that he has thoroughly studied my case before he comes into the exam room. I would not hesitate to recommend him to others. He has the appreciated ability to explain things clearly and concisely.
One star One star One star One star One star	10/23/2024	Always easy 2 talk with
One star One star One star One star One star	10/18/2024	Dr was not in a hurry and listened and answered all my questions and gave his opinion.
One star One star One star One star One star	10/16/2024	Dr. Lowe is an incredibly impressive person. Obviously and highly trained and skilled surgeon but the human side of him is what I and my wife could not stop talking about.
One star One star One star One star One star	10/16/2024	Dr. And staff very pleasant and informative.
One star One star One star One star One star	10/05/2024	Great care given in all aspects of my situation.
One star One star One star One star One star	09/27/2024	He really is the best .
One star One star One star One star One star	09/21/2024	Dr Lowe and staff always professional
One star One star One star One star One star	09/18/2024	Dr. Lowe was great at explaining and let us talk about her care.
One star One star One star One star One star	09/17/2024	Dr Lowe was very attentive and personable as well as emphatic. Additionally gave me treatment options and listened to what was important to me in my care!
One star One star One star One star One star	09/04/2024	Dr Lowe has been absolutely amazing in dealing with not only the surgery to remove the mass, but the scar that was left during the initial biopsy by a different surgeon.
One star One star One star One star One star	08/28/2024	Everyone was great and yes I would recommend Emory.
One star One star One star One star One star	08/23/2024	Dr. Michael Lowe was very professional. He was thorough in explaining my situation on a level that was easy to understand. He had a kind demeanor and caring attitude.
One star One star One star One star One star	08/22/2024	Very good experience.
One star One star One star One star One star	08/21/2024	Dr. Lower and Dr. Lou were very detailed. They gathered medical history, listened ( did not listen and try to record at the same time), allowed me the opportunity to ask questions, gave options for treatment and I was given the opportunity to choose the treatment that I believed was the best plan.
One star One star One star One star One star	08/07/2024	Margi McKellar, PA-CConducted exam & discussion. Very knowledgeable and informative- an excellent addition to Emory Staff
One star One star One star One star One star	08/06/2024	I am very pleased with the care I'm getting at Emory. Dr. Lowe and his staff are excellent.
One star One star One star One star One star	07/30/2024	The PA is always very helpful!
One star One star One star One star One star	07/24/2024	Was great
One star One star One star One star One star	07/24/2024	I highly recommend Dr. Lowe for his expertise in his field and surgical ability.
One star One star One star One star One star	07/05/2024	Very informative and listened well. She went above and beyond to explain my risks and future needs
One star One star One star One star One star	07/03/2024	Very caring
One star One star One star One star One star	06/26/2024	Beyond EXCELLENT Dr. Interaction! Complete and precise explanations during visit!
One star One star One star One star One star	06/26/2024	Compassionate and competent care was provided by nurse, PA and Doctor.
One star One star One star One star One star	06/21/2024	Dr.Lowe was very thorough in his explanations and illustrations about my condition and surgery. He was patient in answering all of our questions. He is extremely knowledgeable and I know I'm in the best of hands with him and the rest of the Emory team.
One star One star One star One star One star	06/21/2024	Dr. Lowe has always been very knowledgeable and professional in my interactions with him.
One star One star One star One star One star	06/19/2024	Dr Lowe was straight forward with information about proceedures and appearent risks
One star One star One star One star One star	06/15/2024	I have had her before and communicated very well
One star One star One star One star One star	06/14/2024	Patience, compassion and sincere care. Very knowledgeable.